
Glaxosmithkline Pharmaceuticals (GLAXO) Share Price Falls 2.17% as Large Cap Pharma Stock Trades Lower
Updated: 18 Nov 2026 • 3:33 pm
Posted by:

Glaxosmithkline Pharmaceuticals Share Price moved to Rs 2,635.15 in today’s trade, down 2.17% from the previous close, while the company’s market capitalisation stood at Rs 44,875.66 crore. According to Univest data, the move is a clear share price fall in a large cap healthcare name, even though no company-specific catalyst is established. The Glaxosmithkline Pharmaceuticals Share Price event matters because the stock is trading at a premium valuation versus the same-industry benchmark while also carrying strong profitability ratios. That combination keeps Glaxosmithkline Pharmaceuticals Share Price in focus for readers tracking Pharma stock news, price action and fundamental analysis. As of 18 November 2026 at 3:23:04 PM IST, the latest Univest figures show a lower intraday level than the open and a narrower trading band than the day began with.
For investors following Glaxosmithkline Pharmaceuticals Share Price Today, the move reflects a decline of Rs 58.40 from the previous close of Rs 2,693.55. The stock opened at Rs 2,685, touched a high of Rs 2,696 and a low of Rs 2,632.35. That range shows Glaxosmithkline Pharmaceuticals Share Price has been moving below the opening level through most of the observed trade. The current market cap keeps the company in the Large Cap category, which is useful context when comparing the Glaxosmithkline Pharmaceuticals Share Price with other healthcare names. In stock market terms, the price event is confirmed, but no company-specific catalyst is established. The next part of the Glaxosmithkline Pharmaceuticals Share Price story is the fundamental picture behind the valuation.
Glaxosmithkline Pharmaceuticals (GLAXO) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,635.15 |
| Previous Close | Rs 2,693.55 |
| Today's Move | -Rs 58.40 (-2.17%) |
| Open | Rs 2,685 |
| High | Rs 2,696 |
| Low | Rs 2,632.35 |
| Market Capitalisation | Rs 44,875.66 crore |
| Market Cap Category | Large Cap |
Glaxosmithkline Pharmaceuticals Share Price was last traded at Rs 2,635.15, which is Rs 58.40 below the previous close of Rs 2,693.55. The day opened at Rs 2,685, and the stock briefly moved up to Rs 2,696 before slipping to a low of Rs 2,632.35. That places Glaxosmithkline Pharmaceuticals Share Price near the lower end of the observed band, with the Large Cap market-cap category offering size context rather than a view on quality. The market capitalisation of Rs 44,875.66 crore shows the company remains a significant listed healthcare franchise. In today’s trade, Glaxosmithkline Pharmaceuticals Share Price has therefore shown a clear downward move against the prior close, and the intraday sequence points to a weaker share price update than the opening level suggested. For readers tracking Glaxosmithkline Pharmaceuticals Share Price Live, the focus now shifts to the balance between price action and financial context.
Glaxosmithkline Pharmaceuticals (GLAXO) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 44,875.66 crore |
| P/E Ratio | 39.8x |
| P/B Ratio | 24.26x |
| ROE | 48.76% |
| ROCE | 66.79% |
| EPS | Rs 67.68 |
| Book Value Per Share | Rs 111.04 |
| Dividend Yield | 2.12% |
Glaxosmithkline Pharmaceuticals (GLAXO) fundamental metrics show P/E 39.8x, P/B 24.26x, ROE 48.76%, ROCE 66.79%. These ratios show where the company stands today and are not a call to buy or sell.
Glaxosmithkline Pharmaceuticals has a market capitalisation of Rs 44,875.66 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 39.8x, P/B at 24.26x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 48.76% and ROCE of 66.79%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 67.68, book value per share of Rs 111.04, dividend yield of 2.12%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.01x, median ROE of 11.33%, median ROCE of 13.1%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 39.8x |
| Benchmark Median P/E | 31.01x |
| Benchmark Average P/E | 58.7x |
| Benchmark P/E Range | 2.75x to 1,425.63x |
| Company P/B Ratio | 24.26x |
| Benchmark Median P/B | 2.88x |
| Benchmark Average P/B | 3.29x |
| Company ROE | 48.76% |
| Benchmark Median ROE | 11.33% |
| Benchmark Average ROE | 4.71% |
| Company ROCE | 66.79% |
| Benchmark Median ROCE | 13.1% |
| Benchmark Average ROCE | 12.06% |
| Company Market Capitalisation | Rs 44,875.66 crore |
| Benchmark Median Market Cap | Rs 791.38 crore |
| Benchmark Average Market Cap | Rs 14,698.18 crore |
Glaxosmithkline Pharmaceuticals (GLAXO) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Glaxosmithkline Pharmaceuticals (GLAXO) has a P/E ratio of 39.8x, which is above the benchmark median of 31.01x, a difference of +28.35%. A P/E difference of this kind is a reference point rather than a recommendation.
Glaxosmithkline Pharmaceuticals (GLAXO) has a ROE of 48.76%, which is above the benchmark median of 11.33%, a difference of +330.36%. Glaxosmithkline Pharmaceuticals (GLAXO) has a ROCE of 66.79%, which is above the benchmark median of 13.1%, a difference of +409.85%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,47,943.84 | 40.92 | 5.03 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,94,962.14 | 87.74 | 16.4 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,78,390.62 | 83.65 | 9.67 | 26.76 | 19.27 |
| Laurus Labs | LAURUSLABS | 1,19,789.92 | 94.36 | 20.86 | 18.31 | 18.2 |
| Zydus Lifesciences | ZYDUSLIFE | 1,18,603.21 | 28.7 | 4.31 | 19.69 | 21.39 |
Glaxosmithkline Pharmaceuticals (GLAXO) has a P/E ratio of 39.8x compared with the displayed peer median of 83.65x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 48.76% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 66.79% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Glaxosmithkline Pharmaceuticals (GLAXO) has a market capitalisation of Rs 44,875.66 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Glaxosmithkline Pharmaceuticals
- Glaxosmithkline Pharmaceuticals Share Price is trading 2.17% lower, so today’s price action is in focus.
- The Large Cap market capitalisation of Rs 44,875.66 crore keeps Glaxosmithkline Pharmaceuticals Share Price in the upper tier of healthcare stocks.
- P/E of 39.8 and P/B of 24.26 place Glaxosmithkline Pharmaceuticals Share Price above the benchmark median on valuation.
- ROE of 48.76% and ROCE of 66.79% give Glaxosmithkline Pharmaceuticals Share Price a strong profitability profile.
- Glaxosmithkline Pharmaceuticals Share Price can be tracked against sector peers, where valuation multiples vary widely.
About Glaxosmithkline Pharmaceuticals
Glaxosmithkline Pharmaceuticals operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is part of India’s listed pharma universe and is tracked by investors for its valuation, profitability and market position. In this market context, Glaxosmithkline Pharmaceuticals Share Price reflects a business with a sizeable market value, strong return ratios and a premium multiple structure. The company’s core identity is linked to pharmaceuticals, with the listed business profile placing it among established healthcare names that are compared with larger and mid-sized peers across the industry. Glaxosmithkline Pharmaceuticals Share Price therefore sits within a sector where quality, valuation and return metrics are regularly assessed together.
Track Glaxosmithkline Pharmaceuticals Share Price on Univest
Use Glaxosmithkline Pharmaceuticals (GLAXO) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Readers can track Glaxosmithkline Pharmaceuticals Share Price on Univest for live price movement, market capitalisation, valuation ratios, 52-week levels and wider market insights. Univest also helps you follow fundamental ratios and compare Glaxosmithkline Pharmaceuticals Share Price with healthcare peers in one place. For stock news readers, it offers a clean way to monitor price updates and company context without noise.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did Glaxosmithkline Pharmaceuticals Share Price fall today?
Ans. Glaxosmithkline Pharmaceuticals Share Price fell 2.17% to Rs 2,635.15. The price move is confirmed in Univest data; a company-specific reason has not been established. The move followed an open of Rs 2,685 and a low of Rs 2,632.35.
What is Glaxosmithkline Pharmaceuticals Share Price today?
Ans. Glaxosmithkline Pharmaceuticals Share Price was last traded at Rs 2,635.15 as of 18 November 2026 at 3:23:04 PM IST. The stock was down Rs 58.40 from the previous close of Rs 2,693.55 in today’s trade.
Is Glaxosmithkline Pharmaceuticals Share Price in the Large Cap category?
Ans. Yes. Glaxosmithkline Pharmaceuticals Share Price belongs to the Large Cap category, with market capitalisation at Rs 44,875.66 crore. That size context is useful when comparing it with other healthcare names in the same industry.
How expensive is Glaxosmithkline Pharmaceuticals Share Price versus the sector?
Ans. Glaxosmithkline Pharmaceuticals Share Price trades at a P/E of 39.8 and P/B of 24.26. Both stand above the same-industry benchmark median of 31.01 on P/E and 2.88 on P/B, suggesting a premium valuation.
What do ROE and ROCE show for Glaxosmithkline Pharmaceuticals Share Price?
Ans. Glaxosmithkline Pharmaceuticals Share Price shows ROE of 48.76% and ROCE of 66.79%. Both are above the benchmark medians of 11.33% and 13.1%, which indicates strong return ratios in the context of the industry set.
What is the EPS and book value behind Glaxosmithkline Pharmaceuticals Share Price?
Ans. Glaxosmithkline Pharmaceuticals Share Price has EPS of Rs 67.68 and book value of Rs 111.04. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share at the current date.
Does Glaxosmithkline Pharmaceuticals Share Price pay a dividend?
Ans. Glaxosmithkline Pharmaceuticals Share Price carries a dividend yield of 2.12%. That figure reflects the historical payout relative to the current price, and it adds an income context to the stock’s valuation profile in healthcare.
How does Glaxosmithkline Pharmaceuticals Share Price compare with peers?
Ans. Glaxosmithkline Pharmaceuticals Share Price has a P/E of 39.8, close to Sun Pharma’s 40.92 and below Divi’s Laboratories, Torrent Pharmaceuticals and Laurus Labs. Its ROE and ROCE are stronger than the peers listed here.
Should investors track Glaxosmithkline Pharmaceuticals Share Price on Univest?
Ans. Yes. Univest lets readers track Glaxosmithkline Pharmaceuticals Share Price alongside market capitalisation, valuation ratios, 52-week levels and company context. That makes it easier to follow stock news and price updates in one place.
Recent Articles

Tata Technologies Share Price Jumps 7% to Rs 704 as FY30 Plan Targets $1.1 to $1.3 Billion Revenue, With JPMorgan's Rs 660 Target Below the Market
19 November 2026

Physicswallah Share Price Target: Motilal Oswal Holds Rs 200 After FY30 Guidance as the Stock Closes 6% Higher at Rs 135.98
19 November 2026

Religare Enterprises (RELIGARE) Share Price Rises 5.09% to Rs 232.25
19 November 2026

Universus Photo Imagings Ltd. Hits Upper Circuit for the 2nd Straight Session on NSE, 19 November 2026
19 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Tata Technologies Share Price Jumps 7% to Rs 704 as FY30 Plan Targets $1.1 to $1.3 Billion Revenue, With JPMorgan's Rs 660 Target Below the Market
Physicswallah Share Price Target: Motilal Oswal Holds Rs 200 After FY30 Guidance as the Stock Closes 6% Higher at Rs 135.98
Religare Enterprises (RELIGARE) Share Price Rises 5.09% to Rs 232.25
Universus Photo Imagings Ltd. Hits Upper Circuit for the 2nd Straight Session on NSE, 19 November 2026
HGS (INDIA) LIMITED Hits Upper Circuit on NSE, 19 November 2026

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





